Edition:
United States

CAS Medical Systems Inc (CASM.OQ)

CASM.OQ on NASDAQ Stock Exchange Capital Market

2.00USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$2.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,910
52-wk High
$2.02
52-wk Low
$0.59

Chart for

About

CAS Medical Systems, Inc. is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring,... (more)
No analyst recommendations are available for .

Overall

Beta: -0.39
Market Cap(Mil.): $55.98
Shares Outstanding(Mil.): 28.71
Dividend: --
Yield (%): --

Financials

  CASM.OQ Industry Sector
P/E (TTM): -- 37.52 33.88
EPS (TTM): -0.03 -- --
ROI: 10.75 8.74 13.21
ROE: -- 12.63 15.18

BRIEF-FDA Clears CASMED's Fore-Sight Tissue Oximetry OEM Module

* CAS MEDICAL SYSTEMS INC - EXPECTS A FILING WITH FDA FOR 510(K) CLEARANCE ON ITS FIRST OEM MODULE COMBINATION PRODUCT BEFORE END OF 2018 Source text for Eikon: Further company coverage:

May 16 2018

BRIEF-Cas Medical Systems Q1 Loss Per Share $0.07

* QUARTERLY NET SALES FROM CONTINUING OPERATIONS $5.4 MILLION VERSUS $4.5 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 10 2018

BRIEF-CAS Medical Systems Says Entered A Loan And Security Agreement With East West Bank Providing A 48-Month Term Loan Of $10 Mln

* CAS MEDICAL SYSTEMS - ENTERED A LOAN AND SECURITY AGREEMENT WITH EAST WEST BANK PROVIDING A 48-MONTH TERM LOAN OF $10 MILLION - SEC FILING

May 08 2018

BRIEF-Cas Medical Systems Says Expects To Receive Regulatory Clearance For OEM Module In Q2 2018

* CAS MEDICAL SYSTEMS INC - EXPECTS TO RECEIVE REGULATORY CLEARANCE FOR OEM MODULE IN Q2 OF 2018

Jan 24 2018

Earnings vs. Estimates